387 related articles for article (PubMed ID: 15578590)
21. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
Ikura T; Ito N
Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
[TBL] [Abstract][Full Text] [Related]
22. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
Kephart DD; Walfish PG; DeLuca H; Butt TR
Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
[TBL] [Abstract][Full Text] [Related]
23. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
Barletta F; Freedman LP; Christakos S
Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
[TBL] [Abstract][Full Text] [Related]
25. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
26. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
Quack M; Carlberg C
Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
28. Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells.
Sun J; Mustafi R; Cerda S; Chumsangsri A; Xia YR; Li YC; Bissonnette M
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):37-40. PubMed ID: 18515093
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
Teske KA; Bogart JW; Sanchez LM; Yu OB; Preston JV; Cook JM; Silvaggi NR; Bikle DD; Arnold LA
Eur J Med Chem; 2016 Feb; 109():238-46. PubMed ID: 26774929
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
31. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
[TBL] [Abstract][Full Text] [Related]
32. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
33. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
34. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Christakos S; Raval-Pandya M; Wernyj RP; Yang W
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
[TBL] [Abstract][Full Text] [Related]
35. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
Tachibana S; Yoshinari K; Chikada T; Toriyabe T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2009 Aug; 37(8):1604-10. PubMed ID: 19460946
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.
Malloy PJ; Xu R; Peng L; Clark PA; Feldman D
Mol Endocrinol; 2002 Nov; 16(11):2538-46. PubMed ID: 12403843
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
Adachi R; Honma Y; Masuno H; Kawana K; Shimomura I; Yamada S; Makishima M
J Lipid Res; 2005 Jan; 46(1):46-57. PubMed ID: 15489543
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
39. Genomic actions of 1,25-dihydroxyvitamin D3.
Whitfield GK; Hsieh JC; Jurutka PW; Selznick SH; Haussler CA; MacDonald PN; Haussler MR
J Nutr; 1995 Jun; 125(6 Suppl):1690S-1694S. PubMed ID: 7782928
[TBL] [Abstract][Full Text] [Related]
40. Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
Cheng J; Fang ZZ; Kim JH; Krausz KW; Tanaka N; Chiang JY; Gonzalez FJ
J Lipid Res; 2014 Mar; 55(3):455-65. PubMed ID: 24343899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]